A Phase I and Biology Study of Gefitinib and Radiation in Children with Newly Diagnosed Brain Stem Gliomas or Supratentorial Malignant Gliomas

PURPOSE: To estimate the maximum tolerated dose (MTD); study the pharmacology of escalating doses of gefitinib combined with radiation therapy in patients ≤21 years with newly diagnosed intrinsic brainstem gliomas (BSG) and incompletely resected supratentorial malignant gliomas (STMG); and to invest...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Geyer, J. Russell, Stewart, Clinton F., Kocak, Mehmet, Broniscer, Alberto, Phillips, Peter, Douglas, James G., Blaney, Susan M., Packer, Roger J., Gururangan, Sri, Banerjee, Anu, Kieran, Mark W., Kun, Larry E., Gilbertson, Richard J., Boyett, James M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2988095/
https://ncbi.nlm.nih.gov/pubmed/20708924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2010.07.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi